Epinephrine and its use in anaphylaxis: Current issues

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 4, 2010, Pages 354-361

  Simons, Keith J ^a   Simons, F Estelle R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

adrenaline; anaphylaxis; epinephrine; epinephrine auto injectors; food allergy; insect venom allergy

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ADRENERGIC RECEPTOR STIMULATING AGENT;

ANAPHYLAXIS; ANXIETY; COMORBIDITY; DIZZINESS; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG MECHANISM; EMERGENCY CARE; HUMAN; HYPERTENSION; LUNG EDEMA; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; DEVICES; DRUG SELF ADMINISTRATION; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED;

ADOLESCENT; ADRENERGIC AGONISTS; ADULT; AGED; ANAPHYLAXIS; ANIMALS; CHILD; EPINEPHRINE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; SELF ADMINISTRATION;

EID: 77954661059     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833bc670     Document Type: Review

References (51)

1. Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's: The pharmacological basis of therapeutics, 11th ed. New York, New York: McGraw-Hill; 2006. pp. 237-247.
2. Simons FER. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 2006; 117:367-377.
3. Kemp SF, Lockey RF, Simons FER. Epinephrine: the drug of choice for anaphylaxis: a statement of the World Allergy Organization. Allergy 2008; 63:1061-1070.
4. Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. Resuscitation 2008; 77:157-169.
5. Brown SGA, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust 2006; 185:283-289.
6. Joint Task Force on Practice Parameters, American Academy of Allergy Asthma and Immunology, American College of Allergy Asthma and Immunology, Joint Council of Allergy Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115:S483-S523.
7. Simons FER, for the World Allergy Organization. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy/immunology specialists in healthcare settings. Ann Allergy Asthma Immunol 2010; 104:405-412.
8. Simons FER. Anaphylaxis. J Allergy Clin Immunol 2010; 125:S161-S181.
9. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002; 110:647-651.
10. Camargo CA Jr, Clark S, Kaplan MS, et al. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol 2007; 120:131-136.
11. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101:139-143.
12. Simons FER. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113:837-844.
13. Simons FER, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101:33-37.
14. Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108:871-873.
15. Simons FER, Gu X, Silver NA, Simons KJ. EpiPen Jr versus EpiPen in young children weighing 15-30 kg at risk for anaphylaxis. J Allergy Clin Immunol 2002; 109:171-175.
16. McLean-Tooke APC, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? Br Med J 2003; 327:1332-1335.
17. Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144-1150.
18. Song TT, Nelson MR, Chang JH, et al. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 2005; 94:539-542.
19. Stecher D, Bulloch B, Sales J, et al. Epinephrine auto-injectors: is needle length adequate for delivery of epinephrine intramuscularly? Pediatrics 2009; 124:65-70.
20. Kanwar M, Irvin CB, Frank JJ, et al. Confusion about epinephrine dosing leading to iatrogenic overdose: a life-threatening problem with a potential solution. Ann Emerg Med 2010; 55:341-344.
21. Triggiani M, Patella V, Staiano RI, et al. Allergy and the cardiovascular system. Clin Exp Immunol 2008; 153 (Suppl 1):7-11.
22. Ridella M, Bagdure S, Nugent K, Cevik C. Kounis syndrome following betalactam antibiotic use: review of literature. Inflamm Allergy Drug Targets 2009; 8:11-16.
23. Biteker M, Duran NE, Biteker FS, et al. Allergic myocardial infarction in childhood: Kounis syndrome. Eur J Pediatr 2010; 169:27-29.
24. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7:337-341.
25. Rueff F, Przybilla B, Bilo MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124:1047-1054.
26. Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2009; 64:204-212.
27. Sheikh A, Ten Broek V, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62: 830-837. (Pubitemid 47037864)
28. Choo KJL, Simons FER, Sheikh A. Glucocorticoids for the treatment of anaphylaxis (review). Cochrane Database Syst Rev 2010;3:CD007596.
29. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119:1016-1018.
30. Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119:1018-1019.
31. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98:252-257.
32. Smith PL, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072-1080.
33. Brown SGA, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis: prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004; 21:149-154.
34. Rawas-Qalaji M, Simons FER, Collins D, Simons KJ. Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis. Ann Allergy Asthma Immunol 2009; 102:500-503.
35. Bautista E, Simons FER, Simons KJ, et al. Epinephrine fails to hasten hemodynamic recovery in fully-developed anaphylactic shock. Int Arch Allergy Immunol 2002; 128:151-164.
36. Scranton SE, Gonzalez EG, Waibel KH. Incidence and characteristics of biphasic reactions after allergen immunotherapy. J Allergy Clin Immunol 2009; 123:493-498.
37. Confino-Cohen R, Goldberg A. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study. Ann Allergy Asthma Immunol 2010; 104:73-78.
38. Sicherer SH, Simons FER. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005; 115:575-583.
39. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112:451-452.
40. Manivannan V, Campbell RL, Bellolio MF, et al. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol 2009; 103:395-400.
41. Rudders SA, Banerji A, Corel B, et al. Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. Pediatrics 2010; 125:e711-e718.
42. Simons FER, for the World Allergy Organization. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community. Ann Allergy Asthma Immunol 2009; 102:403-409.
43. Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Ann Allergy Asthma Immunol 2010; 104:172-177.
44. Campbell RL, Luke A, Weaver AL, et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008; 101: 631-636.
45. Simons FER, Clark S, Camargo CA. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009; 124:301-306.
46. Ben-Shoshan M, Kagan R, Primeau MN, et al. Availability of the epinephrine autoinjector at school in children with peanut allergy. Ann Allergy Asthma Immunol 2008; 100:570-575.
47. Simons FER, Lieberman PL, Read EJ Jr, Edwards ES. Hazards of unintentional injection of epinephrine from auto-injectors: a systematic review. Ann Allergy Asthma Immunol 2009; 102:282-287.
48. Simons FER, Edwards ES, Read EJ Jr, et al. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol 2010; 125:419-423.
49. Nurmatov U, Worth A, Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol 2008; 122:353-361.
50. Rachid O, Simons FER, Rawas-Qalaji M, Simons KJ. An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine. AAPS PharmSciTech 2010; 11:530-537.
51. Simons FER. Emergency treatment of anaphylaxis. BMJ 2008; 336:1141-1142.